Sequential zoledronate therapy prevent rebound bone loss following withdrawal of RANKL inhibition

Small steps in the right direction? Creatinine to Cystatin-C ratio: a biomarker of sarcopenia and falls risk?

Pre-clinical model of transgender bone health